Yuekang Pharmaceutical announced that the company received the “Drug Supplement Application Approval Notice” for injectable cefoxetine sodium (specification: 1.0g) approved and issued by the State Drug Administration. The drug passed the consistent evaluation of the quality and efficacy of generic drugs. This medicine is suitable for treating a variety of serious infections caused by sensitive bacteria, and can also be used to prevent infections before surgery.
悦康药业：注射用头孢西丁钠通过仿制药一致性评价
Yuekang Pharmaceutical: Injectable cefoxitin passed generic drug consistency evaluation
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.